APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Excipients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharma Excipients Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchPharma Excipients Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Excipients Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Pharma Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Excipients Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Excipients Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharma Excipients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharma Excipients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharma Excipients market include J.M. Huber Corporation, Evonik, Eastman Chemical Company, DOW Chemical Company, Cargill, BASF, Archer Daniels Midland (ADM), AkzoNobel and ABITEC Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharma Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharma Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma Excipients Segment by Company

J.M. Huber Corporation

Evonik

Eastman Chemical Company

DOW Chemical Company

Cargill

BASF

Archer Daniels Midland (ADM)

AkzoNobel

ABITEC Corporation

Pharma Excipients Segment by Type

Alcohols

Polymers

Minerals

Sugar

Others

Pharma Excipients Segment by Application

Oral Solid Dosage Forms (OSDF)

Others

Pharma Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pharma Excipients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharma Excipients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharma Excipients significant trends, drivers, influence factors in global and regions.

6. To analyze Pharma Excipients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma Excipients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Excipients industry.

Chapter 3: Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharma Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharma Excipients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharma Excipients Industry Trends Table 2. Pharma Excipients Industry Drivers Table 3. Pharma Excipients Industry Opportunities and Challenges Table 4. Pharma Excipients Industry Restraints Table 5. Global Pharma Excipients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharma Excipients Revenue Share by Company (2021-2026) Table 7. Global Pharma Excipients Sales Volume by Company (W Tons) & (2021-2026) Table 8. Global Pharma Excipients Sales Volume Share by Company (2021-2026) Table 9. Global Pharma Excipients Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pharma Excipients Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharma Excipients Key Company Manufacturing Base & Headquarters Table 12. Global Pharma Excipients Company, Product Type & Application Table 13. Global Pharma Excipients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Alcohols Table 18. Significant Companies of Polymers Table 19. Significant Companies of Minerals Table 20. Significant Companies of Sugar Table 21. Significant Companies of Others Table 22. Global Pharma Excipients Sales Volume by Type 2021 VS 2025 VS 2032 (W Tons) Table 23. Global Pharma Excipients Sales Volume by Type (2021-2026) & (W Tons) Table 24. Global Pharma Excipients Sales Volume by Type (2027-2032) & (W Tons) Table 25. Global Pharma Excipients Sales Volume Share by Type (2021-2026) Table 26. Global Pharma Excipients Sales Volume Share by Type (2027-2032) Table 27. Global Pharma Excipients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharma Excipients Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pharma Excipients Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pharma Excipients Sales Value Share by Type (2021-2026) Table 31. Global Pharma Excipients Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Oral Solid Dosage Forms (OSDF) Table 33. Significant Companies of Others Table 34. Global Pharma Excipients Sales Volume by Application 2021 VS 2025 VS 2032 (W Tons) Table 35. Global Pharma Excipients Sales Volume by Application (2021-2026) & (W Tons) Table 36. Global Pharma Excipients Sales Volume by Application (2027-2032) & (W Tons) Table 37. Global Pharma Excipients Sales Volume Share by Application (2021-2026) Table 38. Global Pharma Excipients Sales Volume Share by Application (2027-2032) Table 39. Global Pharma Excipients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pharma Excipients Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pharma Excipients Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pharma Excipients Sales Value Share by Application (2021-2026) Table 43. Global Pharma Excipients Sales Value Share by Application (2027-2032) Table 44. Global Pharma Excipients Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 45. Global Pharma Excipients Sales by Region (2021-2026) & (W Tons) Table 46. Global Pharma Excipients Sales Market Share by Region (2021-2026) Table 47. Global Pharma Excipients Sales by Region (2027-2032) & (W Tons) Table 48. Global Pharma Excipients Sales Market Share by Region (2027-2032) Table 49. Global Pharma Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pharma Excipients Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pharma Excipients Sales Value Share by Region (2021-2026) Table 52. Global Pharma Excipients Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pharma Excipients Sales Value Share by Region (2027-2032) Table 54. Global Pharma Excipients Market Average Price (US$/Ton) by Region (2021-2026) Table 55. Global Pharma Excipients Market Average Price (US$/Ton) by Region (2027-2032) Table 56. Global Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Table 57. Global Pharma Excipients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 59. Global Pharma Excipients Sales Market Share by Country (2021-2026) Table 60. Global Pharma Excipients Sales by Country (2027-2032) & (W Tons) Table 61. Global Pharma Excipients Sales Market Share by Country (2027-2032) Table 62. Global Pharma Excipients Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pharma Excipients Sales Value Market Share by Country (2021-2026) Table 64. Global Pharma Excipients Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pharma Excipients Sales Value Market Share by Country (2027-2032) Table 66. J.M. Huber Corporation Company Information Table 67. J.M. Huber Corporation Business Overview Table 68. J.M. Huber Corporation Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. J.M. Huber Corporation Pharma Excipients Product Portfolio Table 70. J.M. Huber Corporation Recent Development Table 71. Evonik Company Information Table 72. Evonik Business Overview Table 73. Evonik Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Evonik Pharma Excipients Product Portfolio Table 75. Evonik Recent Development Table 76. Eastman Chemical Company Company Information Table 77. Eastman Chemical Company Business Overview Table 78. Eastman Chemical Company Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Eastman Chemical Company Pharma Excipients Product Portfolio Table 80. Eastman Chemical Company Recent Development Table 81. DOW Chemical Company Company Information Table 82. DOW Chemical Company Business Overview Table 83. DOW Chemical Company Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. DOW Chemical Company Pharma Excipients Product Portfolio Table 85. DOW Chemical Company Recent Development Table 86. Cargill Company Information Table 87. Cargill Business Overview Table 88. Cargill Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Cargill Pharma Excipients Product Portfolio Table 90. Cargill Recent Development Table 91. BASF Company Information Table 92. BASF Business Overview Table 93. BASF Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. BASF Pharma Excipients Product Portfolio Table 95. BASF Recent Development Table 96. Archer Daniels Midland (ADM) Company Information Table 97. Archer Daniels Midland (ADM) Business Overview Table 98. Archer Daniels Midland (ADM) Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio Table 100. Archer Daniels Midland (ADM) Recent Development Table 101. AkzoNobel Company Information Table 102. AkzoNobel Business Overview Table 103. AkzoNobel Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. AkzoNobel Pharma Excipients Product Portfolio Table 105. AkzoNobel Recent Development Table 106. ABITEC Corporation Company Information Table 107. ABITEC Corporation Business Overview Table 108. ABITEC Corporation Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. ABITEC Corporation Pharma Excipients Product Portfolio Table 110. ABITEC Corporation Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Pharma Excipients Distributors List Table 114. Pharma Excipients Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Pharma Excipients Product Image Figure 2. Global Pharma Excipients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Excipients Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharma Excipients Sales (2021-2032) & (W Tons) Figure 5. Global Pharma Excipients Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pharma Excipients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Alcohols Image Figure 10. Polymers Image Figure 11. Minerals Image Figure 12. Sugar Image Figure 13. Others Image Figure 14. Global Pharma Excipients Sales Volume by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Pharma Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pharma Excipients Sales Volume Share by Type (2021-2032) Figure 17. Global Pharma Excipients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharma Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharma Excipients Sales Value Share by Type (2021-2032) Figure 20. Oral Solid Dosage Forms (OSDF) Image Figure 21. Others Image Figure 22. Global Pharma Excipients Sales Volume by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 23. Global Pharma Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pharma Excipients Sales Volume Share by Application (2021-2032) Figure 25. Global Pharma Excipients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pharma Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pharma Excipients Sales Value Share by Application (2021-2032) Figure 28. Global Pharma Excipients Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 29. Global Pharma Excipients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pharma Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pharma Excipients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pharma Excipients Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pharma Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pharma Excipients Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pharma Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pharma Excipients Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pharma Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pharma Excipients Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pharma Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pharma Excipients Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pharma Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pharma Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pharma Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pharma Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pharma Excipients Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pharma Excipients Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Alcohols
  • Polymers
  • Minerals
  • Sugar
  • Others
Applications
  • Oral Solid Dosage Forms (OSDF)
  • Others
Companies covered
  • J.M. Huber Corporation
  • Evonik
  • Eastman Chemical Company
  • DOW Chemical Company
  • Cargill
  • BASF
  • Archer Daniels Midland (ADM)
  • AkzoNobel
  • ABITEC Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Excipients Sales Value (2021-2032)
  4. 1.2.2 Global Pharma Excipients Sales Volume (2021-2032)
  5. 1.2.3 Global Pharma Excipients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharma Excipients Market Dynamics
  1. 2.1 Pharma Excipients Industry Trends
  2. 2.2 Pharma Excipients Industry Drivers
  3. 2.3 Pharma Excipients Industry Opportunities and Challenges
  4. 2.4 Pharma Excipients Industry Restraints
3 Pharma Excipients Market by Company
  1. 3.1 Global Pharma Excipients Company Revenue Ranking in 2025
  2. 3.2 Global Pharma Excipients Revenue by Company (2021-2026)
  3. 3.3 Global Pharma Excipients Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharma Excipients Average Price by Company (2021-2026)
  5. 3.5 Global Pharma Excipients Company Ranking (2024-2026)
  6. 3.6 Global Pharma Excipients Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharma Excipients Company Product Type and Application
  8. 3.8 Global Pharma Excipients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharma Excipients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharma Excipients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharma Excipients Market by Type
  1. 4.1 Pharma Excipients Type Introduction
  2. 4.1.1 Alcohols
  3. 4.1.2 Polymers
  4. 4.1.3 Minerals
  5. 4.1.4 Sugar
  6. 4.1.5 Others
  7. 4.2 Global Pharma Excipients Sales Volume by Type
  8. 4.2.1 Global Pharma Excipients Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharma Excipients Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pharma Excipients Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pharma Excipients Sales Value by Type
  12. 4.3.1 Global Pharma Excipients Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pharma Excipients Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pharma Excipients Sales Value Share by Type (2021-2032)
5 Pharma Excipients Market by Application
  1. 5.1 Pharma Excipients Application Introduction
  2. 5.1.1 Oral Solid Dosage Forms (OSDF)
  3. 5.1.2 Others
  4. 5.2 Global Pharma Excipients Sales Volume by Application
  5. 5.2.1 Global Pharma Excipients Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharma Excipients Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pharma Excipients Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pharma Excipients Sales Value by Application
  9. 5.3.1 Global Pharma Excipients Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pharma Excipients Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pharma Excipients Sales Value Share by Application (2021-2032)
6 Pharma Excipients Regional Sales and Value Analysis
  1. 6.1 Global Pharma Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Pharma Excipients Sales by Region: 2021-2026
  4. 6.2.2 Global Pharma Excipients Sales by Region (2027-2032)
  5. 6.3 Global Pharma Excipients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharma Excipients Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharma Excipients Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharma Excipients Sales Value by Region (2027-2032)
  9. 6.5 Global Pharma Excipients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharma Excipients Sales Value (2021-2032)
  12. 6.6.2 North America Pharma Excipients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharma Excipients Sales Value (2021-2032)
  15. 6.7.2 Europe Pharma Excipients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharma Excipients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharma Excipients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharma Excipients Sales Value (2021-2032)
  21. 6.9.2 South America Pharma Excipients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharma Excipients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharma Excipients Sales Value Share by Country, 2025 VS 2032
7 Pharma Excipients Country-level Sales and Value Analysis
  1. 7.1 Global Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharma Excipients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharma Excipients Sales by Country (2021-2032)
  4. 7.3.1 Global Pharma Excipients Sales by Country (2021-2026)
  5. 7.3.2 Global Pharma Excipients Sales by Country (2027-2032)
  6. 7.4 Global Pharma Excipients Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharma Excipients Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharma Excipients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharma Excipients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharma Excipients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharma Excipients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharma Excipients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharma Excipients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharma Excipients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharma Excipients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharma Excipients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharma Excipients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharma Excipients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharma Excipients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharma Excipients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharma Excipients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharma Excipients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharma Excipients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharma Excipients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharma Excipients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharma Excipients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharma Excipients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharma Excipients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharma Excipients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharma Excipients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharma Excipients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharma Excipients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharma Excipients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharma Excipients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharma Excipients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharma Excipients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharma Excipients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharma Excipients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharma Excipients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 J.M. Huber Corporation
  2. 8.1.1 J.M. Huber Corporation Company Information
  3. 8.1.2 J.M. Huber Corporation Business Overview
  4. 8.1.3 J.M. Huber Corporation Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 J.M. Huber Corporation Pharma Excipients Product Portfolio
  6. 8.1.5 J.M. Huber Corporation Recent Developments
  7. 8.2 Evonik
  8. 8.2.1 Evonik Company Information
  9. 8.2.2 Evonik Business Overview
  10. 8.2.3 Evonik Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Evonik Pharma Excipients Product Portfolio
  12. 8.2.5 Evonik Recent Developments
  13. 8.3 Eastman Chemical Company
  14. 8.3.1 Eastman Chemical Company Company Information
  15. 8.3.2 Eastman Chemical Company Business Overview
  16. 8.3.3 Eastman Chemical Company Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eastman Chemical Company Pharma Excipients Product Portfolio
  18. 8.3.5 Eastman Chemical Company Recent Developments
  19. 8.4 DOW Chemical Company
  20. 8.4.1 DOW Chemical Company Company Information
  21. 8.4.2 DOW Chemical Company Business Overview
  22. 8.4.3 DOW Chemical Company Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DOW Chemical Company Pharma Excipients Product Portfolio
  24. 8.4.5 DOW Chemical Company Recent Developments
  25. 8.5 Cargill
  26. 8.5.1 Cargill Company Information
  27. 8.5.2 Cargill Business Overview
  28. 8.5.3 Cargill Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cargill Pharma Excipients Product Portfolio
  30. 8.5.5 Cargill Recent Developments
  31. 8.6 BASF
  32. 8.6.1 BASF Company Information
  33. 8.6.2 BASF Business Overview
  34. 8.6.3 BASF Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BASF Pharma Excipients Product Portfolio
  36. 8.6.5 BASF Recent Developments
  37. 8.7 Archer Daniels Midland (ADM)
  38. 8.7.1 Archer Daniels Midland (ADM) Company Information
  39. 8.7.2 Archer Daniels Midland (ADM) Business Overview
  40. 8.7.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio
  42. 8.7.5 Archer Daniels Midland (ADM) Recent Developments
  43. 8.8 AkzoNobel
  44. 8.8.1 AkzoNobel Company Information
  45. 8.8.2 AkzoNobel Business Overview
  46. 8.8.3 AkzoNobel Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AkzoNobel Pharma Excipients Product Portfolio
  48. 8.8.5 AkzoNobel Recent Developments
  49. 8.9 ABITEC Corporation
  50. 8.9.1 ABITEC Corporation Company Information
  51. 8.9.2 ABITEC Corporation Business Overview
  52. 8.9.3 ABITEC Corporation Pharma Excipients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ABITEC Corporation Pharma Excipients Product Portfolio
  54. 8.9.5 ABITEC Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma Excipients Value Chain Analysis
  2. 9.1.1 Pharma Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma Excipients Sales Mode & Process
  6. 9.2 Pharma Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma Excipients Distributors
  9. 9.2.3 Pharma Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst